This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Frankly Speaking CME 235

Podcast

Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking EP 235Guest: Alan M. Ehrlich, MD, FAAFP
Music Credit: Richard Onorato

Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach.

Episode References and Resources: 

  • Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373
     

Begin

Already listened on another platform?

Claim Credits

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 8/2/2021

Expiration Date: 8/2/2022

Learning Objectives

  • Discuss treatment options for perennial allergic rhinitis
  • Explain how to counsel patients about the pros and cons of PRN intranasal steroid treatment
     

     

 

Faculty

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Learn More

Alan M. Ehrlich, MD, FAAFP

Associate Professor of Family Medicine and Community Health, University of Massachusetts Medical School,
Executive Editor, DynaMed 

Learn More

Supporters and Partners

Commercial Supporter

Not Applicable

Education Partner

Not Applicable

Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking EP 235

Begin